Healius Ltd (HLS.AX) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Services · Australia · ISIN AU0000033359
Healius Ltd financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 1.34 bn AUD | 1.37 bn AUD |
| Gross profit | 398.60 m AUD | 254.00 m AUD |
| Operating income | 200,000.00 AUD | 30.20 m AUD |
| EBIT | 200,000.00 AUD | – |
| Net income | -151.20 m AUD | -415.60 m AUD |
| Diluted EPS – continuing operations | -0.21 AUD | -0.57 AUD |
Full history since 1998, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Healius Ltd
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab Dermatopathology, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
More stocks
- Shenzhen Friendcom Technology Development Co Ltd (300514.SZ)
- Shenzhen Wenke Landscape Co Ltd (002775.SZ)
- Burgenland Holding Aktiengesellschaft (BHD.VI)
- Serve Robotics Inc. /DE/ (SERV)
- Ranger Energy Services, Inc. (RNGR)
- Putnam Managed Municipal Income Closed Fund (PMM)
- BILI Social International, Inc. (BSCL)
- Liton Technology (6175.TWO)
- READING INTERNATIONAL INC (RDIB)
- Complete Fin Solu (CFSU)
- TRANSILVANIA INVESTMENTS ALLIANCE S.A. (TRANSI.RO)
- ALICO, INC. (ALCO)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.